Donald Kelemen, Ph.D., is Chief Scientific Officer at ABITEC Corporation, a global leader in lipid chemistry and formulation technologies for pharmaceutical and nutritional applications. Kelemen oversees the development of high-purity lipids and custom excipients that support a wide range of advanced therapeutic platforms, including lipid nanoparticles. He holds a Ph.D. in Nutrition and Biotechnology and has over 20 years of experience in the pharmaceutical industry.